FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2872868611> ?p ?o ?g. }

• W2872868611 endingPage "202" @default.
• W2872868611 startingPage "191" @default.
• W2872868611 abstract "A series of N-(2-(3,4,5-trimethoxybenzyl)-benzoxazole-5-yl)benzamide derivatives (3a–3n) was synthesized and evaluated for its in vitro inhibitory activity against COX-1 and COX-2. The compounds with considerable in vitro activity (IC50 < 1 µM), were evaluated in vivo for their anti-inflammatory and ulcerogenic potential. Out of the fourteen newly synthesized compounds; 3b, 3d, 3e, 3h, 3l and 3m were found to be most potent COX-2 inhibitors in in vitro enzymatic assay with IC50 in the range of 0.14–0.69 µM. In vivo anti-inflammatory activity of these six compounds (3b, 3d, 3e, 3h, 3l and 3m) was assessed by carrageenan induced rat paw edema method. The compound 3b (79.54%), 3l (75.00%), 3m (72.72%) and 3d (68.18%) exhibited significant anti-inflammatory activity than standard drug ibuprofen (65.90%). Ulcerogenic activity with histopathological studies was performed, and the screened compounds demonstrated significant gastric tolerance than ibuprofen. Molecular Docking study was also performed with resolved crystal structure of COX-2 to understand the interacting mechanisms of newly synthesized inhibitors with the active site of COX-2 enzyme and the results were found to be in line with the biological evaluation studies of the compounds." @default.
• W2872868611 created "2018-07-19" @default.
• W2872868611 creator A5005434491 @default.
• W2872868611 creator A5014295007 @default.
• W2872868611 creator A5018891045 @default.
• W2872868611 creator A5020762211 @default.
• W2872868611 creator A5025803819 @default.
• W2872868611 creator A5059709183 @default.
• W2872868611 creator A5069694215 @default.
• W2872868611 date "2018-12-01" @default.
• W2872868611 modified "2023-10-14" @default.
• W2872868611 title "Synthesis, biological evaluation and docking study of N-(2-(3,4,5-trimethoxybenzyl)benzoxazole-5-yl) benzamide derivatives as selective COX-2 inhibitor and anti-inflammatory agents" @default.
• W2872868611 cites W148675321 @default.
• W2872868611 cites W1489401143 @default.
• W2872868611 cites W1529802913 @default.
• W2872868611 cites W1640671675 @default.
• W2872868611 cites W1842834074 @default.
• W2872868611 cites W194925382 @default.
• W2872868611 cites W1964103520 @default.
• W2872868611 cites W1964169703 @default.
• W2872868611 cites W1973648473 @default.
• W2872868611 cites W1977791869 @default.
• W2872868611 cites W1978397440 @default.
• W2872868611 cites W1979311021 @default.
• W2872868611 cites W1981819970 @default.
• W2872868611 cites W1988861578 @default.
• W2872868611 cites W1993181047 @default.
• W2872868611 cites W1998545166 @default.
• W2872868611 cites W2003714242 @default.
• W2872868611 cites W2011384588 @default.
• W2872868611 cites W2023232134 @default.
• W2872868611 cites W2025816743 @default.
• W2872868611 cites W2033843432 @default.
• W2872868611 cites W2045884375 @default.
• W2872868611 cites W2060702261 @default.
• W2872868611 cites W2060937432 @default.
• W2872868611 cites W2070609164 @default.
• W2872868611 cites W2073665106 @default.
• W2872868611 cites W2084184495 @default.
• W2872868611 cites W2087722410 @default.
• W2872868611 cites W2113064542 @default.
• W2872868611 cites W2117774985 @default.
• W2872868611 cites W2119142885 @default.
• W2872868611 cites W2123107310 @default.
• W2872868611 cites W2129373794 @default.
• W2872868611 cites W2155862582 @default.
• W2872868611 cites W2173940926 @default.
• W2872868611 cites W2175918357 @default.
• W2872868611 cites W2237661140 @default.
• W2872868611 cites W2315008638 @default.
• W2872868611 cites W2345734777 @default.
• W2872868611 cites W2499929567 @default.
• W2872868611 cites W2563604601 @default.
• W2872868611 cites W2591623378 @default.
• W2872868611 cites W2605678080 @default.
• W2872868611 cites W2707437696 @default.
• W2872868611 cites W2759191832 @default.
• W2872868611 cites W2783703963 @default.
• W2872868611 cites W2790062274 @default.
• W2872868611 cites W2793917419 @default.
• W2872868611 cites W2796828818 @default.
• W2872868611 cites W2950383642 @default.
• W2872868611 cites W4248107770 @default.
• W2872868611 doi "https://doi.org/10.1016/j.bioorg.2018.07.007" @default.
• W2872868611 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30138907" @default.
• W2872868611 hasPublicationYear "2018" @default.
• W2872868611 type Work @default.
• W2872868611 sameAs 2872868611 @default.
• W2872868611 citedByCount "12" @default.
• W2872868611 countsByYear W28728686112019 @default.
• W2872868611 countsByYear W28728686112020 @default.
• W2872868611 countsByYear W28728686112021 @default.
• W2872868611 countsByYear W28728686112022 @default.
• W2872868611 countsByYear W28728686112023 @default.
• W2872868611 crossrefType "journal-article" @default.
• W2872868611 hasAuthorship W2872868611A5005434491 @default.
• W2872868611 hasAuthorship W2872868611A5014295007 @default.
• W2872868611 hasAuthorship W2872868611A5018891045 @default.
• W2872868611 hasAuthorship W2872868611A5020762211 @default.
• W2872868611 hasAuthorship W2872868611A5025803819 @default.
• W2872868611 hasAuthorship W2872868611A5059709183 @default.
• W2872868611 hasAuthorship W2872868611A5069694215 @default.
• W2872868611 hasConcept C150903083 @default.
• W2872868611 hasConcept C159110408 @default.
• W2872868611 hasConcept C178790620 @default.
• W2872868611 hasConcept C181199279 @default.
• W2872868611 hasConcept C185592680 @default.
• W2872868611 hasConcept C202751555 @default.
• W2872868611 hasConcept C207001950 @default.
• W2872868611 hasConcept C2777752497 @default.
• W2872868611 hasConcept C2778047396 @default.
• W2872868611 hasConcept C2779703632 @default.
• W2872868611 hasConcept C2779944601 @default.
• W2872868611 hasConcept C2780231548 @default.
• W2872868611 hasConcept C41685203 @default.
• W2872868611 hasConcept C55493867 @default.
• W2872868611 hasConcept C71240020 @default.
• W2872868611 hasConcept C71924100 @default.

• next